Advertisement
Screener

JPMORGAN CHASE & CO (JPM) Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings

JPMORGAN CHASE & CO Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings

JPMORGAN CHASE & CO (JPM) reported Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings of $2.00 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-02.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings · last filed 2020-11-02

  • JPMORGAN CHASE & CO other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2020-09-30 was $2.00M.
  • JPMORGAN CHASE & CO other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2019-12-31 was $0.00.
  • JPMORGAN CHASE & CO other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
  • JPMORGAN CHASE & CO other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
  • JPMORGAN CHASE & CO other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2019 was $0.00.
  • JPMORGAN CHASE & CO other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
  • JPMORGAN CHASE & CO other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2017 was $7.00M, a 75.00% decline from fiscal 2016.
  • JPMORGAN CHASE & CO other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2016 was $28.00M.
Period endOther-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 3 monthOther-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 6 monthOther-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 9 monthOther-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 12 month
2020-09-30$2.00M
10-Q · filed 2020-11-02
$2.00M
10-Q · filed 2020-11-02
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$0.00
derived: sum of 2 quarters · filed 2020-11-02
$0.00
derived: sum of 3 quarters · filed 2020-11-02
$0.00
10-K · filed 2020-02-25
2019-09-30$0.00
10-Q · filed 2020-11-02
$0.00
derived: sum of 2 quarters · filed 2020-11-02
$0.00
10-Q · filed 2020-11-02
-$1.00M
derived: sum of 4 quarters · filed 2020-11-02
2019-06-30$0.00
10-Q · filed 2019-08-06
$0.00
10-Q · filed 2019-08-06
-$1.00M
derived: sum of 3 quarters · filed 2020-02-25
$0.00
derived: sum of 4 quarters · filed 2020-02-25
2019-03-31$0.00
10-Q · filed 2019-05-02
-$1.00M
derived: sum of 2 quarters · filed 2020-02-25
$0.00
derived: sum of 3 quarters · filed 2020-02-25
$1.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$0.00
derived: sum of 2 quarters · filed 2020-02-25
$1.00M
derived: sum of 3 quarters · filed 2020-02-25
$0.00
10-K · filed 2020-02-25
2018-09-30$1.00M
10-Q · filed 2019-11-04
$2.00M
derived: sum of 2 quarters · filed 2019-11-04
$1.00M
10-Q · filed 2019-11-04
$23.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$1.00M
10-Q · filed 2019-08-06
$1.00M
10-Q · filed 2019-08-06
$22.00M
derived: sum of 3 quarters · filed 2020-02-25
$22.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$20.00M
10-Q · filed 2019-05-02
$21.00M
derived: sum of 2 quarters · filed 2020-02-25
$21.00M
derived: sum of 3 quarters · filed 2020-02-25
2017-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$1.00M
derived: sum of 2 quarters · filed 2020-02-25
$7.00M
10-K · filed 2020-02-25
2017-09-30$0.00
10-Q · filed 2018-10-31
$6.00M
10-Q · filed 2018-10-31
2016-12-31$28.00M
10-K · filed 2019-02-26